Why 90% failure hides the real survival milestones

"90% of startups fail."

You've heard that line so many times it's basically elevator music. It's also almost useless for making real decisions about your company.

What matters is where they fail, when they fail, and which kinds of companies are dying vs surviving.

The Real Problem with the 90% Number

"90% fail" is like saying "most humans die." True, but not helpful.

If you want clarity as a founder, you need to think in survival curves, not a single big failure number. The game is a series of gates: each funding stage, each year of survival, each vertical has its own odds. Once you see those gates, the world stops feeling like a vague death sentence and starts looking like a map.

Stop Thinking in Coin Flips. Start Thinking in Gates.

The 90% number mashes everything together: bootstrapped and venture-backed. SaaS, biotech, hardware, games, crypto. Dead-in-18-months and slow-profitables that never "exit."

Lumped together, it's noise.

The more useful way to think about it is conditional survival: "Given I made it to X, what are my odds of reaching Y?"

Here's what very rough venture-backed survival looks like (US/Europe, last decade-ish, all verticals mixed):

• From pre-seed → seed: maybe 30–50% raise a real seed
• From seed → Series A: maybe 25–40% raise A
• From Series A → Series B: maybe 40–60%
• From Series B → meaningful exit (IPO, $200M+ sale): maybe 20–30%

Chain those together and, yes, the overall odds are brutal. But your real question is not "what are my global odds?" It's: "Given I'm a funded seed SaaS company in 2024, how likely is it I hit Series A, and what has to be true for that to happen?"

That's a very different question than "do 90% fail."

Your Vertical Completely Rewrites the Survival Curve

Survival curves are not the same across industries. At all.

Some rough patterns (not gospel, but closer to reality than "90% fail"):

B2B SaaS (good gross margins, recurring) – More companies make it to seed/A, because the story is easy to underwrite. But many plateau after A/B if growth slows below ~2–3x year-over-year. A "serious" seed today might be $1–3M ARR within ~18–24 months, growing 10–20% MoM early on.

Consumer apps / marketplaces – Huge pre-seed/seed graveyard. Many never find repeatable acquisition. The ones that work can raise very fast because top-line user growth is explosive. You see more "zero or rocket ship" behavior vs. SaaS's steadier slope.

Fintech – Harder early (regulation, licenses, underwriting, trust). Surviving to Series B can be very valuable: infra, switching costs, and regulatory moats kick in.

Biotech / deep tech / hardware – Higher early failure from technical risk or funding gaps. But investors know this, so the conditional survival from, say, Series A to exit can actually be better than in generic SaaS. Once a drug hits Phase 2/3 or a hardware platform hits production, the odds profile changes a lot.

Crypto / frontier / "weird stuff" – Survival often depends more on cycles than on your own execution. Time-to-next-round is heavily tied to whether your narrative matches the current hype window.

So you don't want "startup failure odds." You want "survival curve for my specific type of company, in this fundraising climate."

Time and Trajectory Matter More Than Alive vs Dead

Binary "failed/succeeded" hides the thing that actually kills you: running out of time.

Two companies can both be "alive" at 24 months and still be in totally different universes. Company A: $40k MRR, 8 months runway, growing 12% MoM, clean cap table. Company B: $5k MRR, 2 months runway, flat growth, messy cap table.

Same age. Completely different survival odds.

Better questions than "will I be in the 10%?":

Time to next gate – For your stage and vertical, how long does it usually take to hit the metrics for the next round? 12 months? 24?

Round-to-round bar – What are investors actually funding at that gate right now? (e.g., Seed → A: often $1–3M ARR, 3x+ YoY growth, or very strong usage/retention for non-revenue products.)

Runway vs learning speed – Are you iterating fast enough that each month of burn buys real information about the business?

You want a simple mental model: "Given my runway and current trajectory, how many realistic shots at the next milestone do I have?"

That's a more useful number than 90%.

Compare Yourself to the Right Cohort

If you raised $500k from angels and are comparing yourself to a startup that raised $8M seed from top-tier VCs, you'll feel like you're failing even if you're actually ahead for your lane.

Useful cohort filters:

• Funding size & type (bootstrapped, angel, pre-seed, institutional seed)
• Vertical & business model (B2B SaaS vs consumer subscription vs hard tech)
• Starting year (2019-vintage SaaS vs 2023-vintage SaaS are in totally different markets)
• Geo (Bay Area SaaS with access to 50+ seed funds is not the same as Eastern Europe SaaS with 3 local funds)

Once you slice by those, survival rates look very different from the spooky 90%. Some cohorts are more like "50% die before seed, another 40% between seed and A, the rest battle it out over a decade."

How to Use This Tomorrow

Use "90% fail" as a mood, not a metric.

For decisions, build your own survival map:

1. Define your cohort: stage, vertical, model, funding size, geography, starting year.
2. Ask: what does "good enough to raise the next round" look like for companies like mine right now (ARR, growth, retention, unit economics)?
3. Estimate: number of months of runway / number of plausible pivots or big swings you can take.
4. Orient around gates: everything you do should increase the conditional probability you make it through the next gate, not some abstract exit.

Once you stop fearing a vague 90% and start optimizing for your own curve, fundraising and product decisions get much simpler: "What is the next gate, what's the bar, and what's the fastest way to hit it with the money and time I have?"